WELTERBI-250 contains Terbinafine 250 mg, an oral allylamine antifungal formulated for the treatment of susceptible dermatophyte infections. A strong PCD Pharma Derma & Anti-Fungal portfolio offering.
Dermatophyte fungal infections, including selected nail and skin infections.
No; activity depends on the fungal organism.
Use exactly as prescribed. Inform the physician about liver disease and report persistent nausea, dark urine, jaundice or unusual fatigue. Complete the prescribed course.
Headache, nausea, diarrhea, abdominal discomfort, taste disturbance and skin reactions may occur. Liver injury is a rare but important concern with oral therapy.
WELTERBI-250: Terbinafine inhibits fungal squalene epoxidase, causing depletion of ergosterol and accumulation of toxic squalene within fungal cells, resulting in fungal death.
